job that's good for you, and for Australia. About the Team The Citrus & Grapes Finance Team is located variously in regions... reporting requirements, is essential. About the Role Reporting to the Finance Business Partner based in our Dockland's Head...
Finance team is the primary accounting, reporting and control function for all treasury related activity, with responsibility... and securitisation accounting, funds transfer pricing and treasury related regulatory returns. Both the Treasury and Treasury Finance...
We support and value your professional development Be part of our growing Corporate Finance business in Victoria... to medium, enterprise customers and our regional and agribusiness customers. The Corporate Finance team sits within the Major...
, energetic and organised Finance Officer to process a wide range of financial transactions across multiple portfolios..., accurate and efficient finance transactions processing and data entry related to accounts payable, invoicing, journal entries...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »